SciMed Biotech Podcast with Shane Hegarty of Axonis Therapeutics

Dr. Shane Hegarty's Pioneering Journey with Axonis Therapeutics Revolutionizes CNS Treatments

In this episode of the SciMed Biotech Podcast, join Dr. Shane Hegarty, the visionary Chief Scientific Officer and Co-Founder of Axonis Therapeutics, as he shares his journey into the world of neurotherapeutics. With a career that bridges deep scientific research and innovative biotech entrepreneurship, Dr. Hegarty reveals how his personal experiences and scientific expertise have culminated in the development of Axonis's pioneering treatments for neurological disorders.

Discover how Axonis, leveraging insights from cutting-edge genome-wide AAV-CRISPR screens and the leadership in KCC2 biology, is poised to transform the treatment landscape for conditions like epilepsy, pain, and other CNS pathologies. Dr. Hegarty discusses the challenges and successes of transitioning from academia to the biotech industry, his strategic approach to overcoming funding obstacles, and the exciting potential of KCC2 potentiators that Axonis is bringing to clinical trials.

Tune in to learn how Dr. Hegarty's passion for science and commitment to patient care are driving innovations that promise to significantly improve the lives of those suffering from debilitating neurological conditions. This episode is not just a tale of scientific achievement but a compelling look at how visionary leadership can turn promising research into life-changing therapeutic applications.